Streetbeat News

Price Targets

BRZE

Piper Sandler analyst Brent Bracelin maintains an Overweight rating on Braze (NASDAQ:BRZE) and raises the price target from $45 to $57.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:31 am

AI

Piper Sandler analyst Arvind Ramnani has maintained a Neutral rating on C3.ai (NYSE:AI) and lowered the price target from $29 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:30 am

INTA

Piper Sandler analyst Arvind Ramnani has maintained an Overweight rating on Intapp (NASDAQ:INTA) but lowered the price target from $49 to $46.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:28 am

NOG

Raymond James analyst John Freeman maintains a Strong Buy rating on Northern Oil & Gas (NYSE:NOG) and has raised the price target from $44 to $54.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:24 am

CBAY

Raymond James analyst Steven Seedhouse maintains a Strong Buy rating on CymaBay Therapeutics (NASDAQ:CBAY) and has raised the price target from $17 to $33.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:24 am

TENB

Needham analyst Mike Cikos has reiterated a 'Buy' rating on Tenable Holdings (NASDAQ:TENB) and maintained a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:23 am

MREO

Needham analyst Gil Blum has reiterated a 'Buy' rating on Mereo BioPharma Group (NASDAQ:MREO) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:21 am

CDTX

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Cidara Therapeutics (NASDAQ:CDTX) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:17 am

GIII

Keybanc analyst Noah Zatzkin maintains an Overweight rating on G-III Apparel Group (NASDAQ:GIII) and raises the price target from $23 to $26.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:16 am

CHPT

Needham analyst Chris Pierce maintained a Buy rating for ChargePoint Holdings Inc (NYSE:CHPT) but lowered the price target from $13 to $9. The re-rating reflects 2Q results, company commentary, lower estimates, and a lower target multiple. Economic uncertainty and delays in vehicle electrification have driven CHPT revenue estimates lower for the third consecutive quarter. Despite this, Pierce views CHPT as a key player in EV adoption. However, slower growth in CHPT revenue despite faster EV adoption is lowering investor confidence.

Portfolio Pulse from Anusuya Lahiri

September 07, 2023 | 7:57 pm